- Home
- HOTH vs SILO Comparison
HOTH vs SILO Comparison
Compare HOTH & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- SILO
- Stock Information
- Founded
- HOTH 2017
- SILO 2010
- Country
- HOTH United States
- SILO United States
- Employees
- HOTH N/A
- SILO N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- SILO Apparel
- Sector
- HOTH Health Care
- SILO Consumer Discretionary
- Exchange
- HOTH Nasdaq
- SILO Nasdaq
- Market Cap
- HOTH 15.6M
- SILO 5.9M
- IPO Year
- HOTH 2019
- SILO N/A
- Fundamental
- Price
- HOTH $1.82
- SILO $0.81
- Analyst Decision
- HOTH Strong Buy
- SILO
- Analyst Count
- HOTH 3
- SILO 0
- Target Price
- HOTH $4.00
- SILO N/A
- AVG Volume (30 Days)
- HOTH 1.9M
- SILO 337.6K
- Earning Date
- HOTH 11-11-2025
- SILO 11-11-2025
- Dividend Yield
- HOTH N/A
- SILO N/A
- EPS Growth
- HOTH N/A
- SILO N/A
- EPS
- HOTH N/A
- SILO N/A
- Revenue
- HOTH N/A
- SILO $72,102.00
- Revenue This Year
- HOTH N/A
- SILO $1.86
- Revenue Next Year
- HOTH N/A
- SILO N/A
- P/E Ratio
- HOTH N/A
- SILO N/A
- Revenue Growth
- HOTH N/A
- SILO N/A
- 52 Week Low
- HOTH $0.65
- SILO $0.41
- 52 Week High
- HOTH $3.80
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- HOTH 79.26
- SILO 67.54
- Support Level
- HOTH $1.53
- SILO $0.58
- Resistance Level
- HOTH $1.80
- SILO $0.70
- Average True Range (ATR)
- HOTH 0.13
- SILO 0.04
- MACD
- HOTH 0.05
- SILO 0.01
- Stochastic Oscillator
- HOTH 92.96
- SILO 91.94
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.